{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:03:00Z","timestamp":1789689780940,"version":"4.0.1"},"reference-count":31,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2024,8,9]]},"DOI":"10.1253\/circrep.cr-24-0061","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:10:31Z","timestamp":1721686231000},"page":"283-293","source":"Crossref","is-referenced-by-count":10,"title":["Patient Outcomes in Very Elderly Patients With Non-Valvular Atrial Fibrillation\u3000\u2015 ANAFIE Registry \u2015"],"prefix":"10.1253","volume":"6","author":[{"given":"Shinya","family":"Suzuki","sequence":"first","affiliation":[{"name":"The Cardiovascular Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"The Cardiovascular Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Akao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kyoto Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Atarashi","sequence":"additional","affiliation":[{"name":"Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Okumura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Koretsune","sequence":"additional","affiliation":[{"name":"National Hospital Organization Osaka National Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School, Tama Nagayama Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tsutsui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Department of Medicine, Osaka Fukujyuji Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yasaka","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, Fukuoka Neurosurgical Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Morishima","sequence":"additional","affiliation":[{"name":"Primary Medical Science Department, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Fukuzawa","sequence":"additional","affiliation":[{"name":"Primary Medical Science Department, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takita","sequence":"additional","affiliation":[{"name":"Data Intelligence Department, Daiichi Sankyo Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Saiseikai Toyama Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, et al. Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination. <i>Int J Cardiol<\/i> 2009; 137: 102\u2013107.","DOI":"10.1016\/j.ijcard.2008.06.029"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk factors in Atrial fibrillation (ATRIA) Study. <i>JAMA<\/i> 2001; 285: 2370\u20132375.","DOI":"10.1001\/jama.285.18.2370"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. <i>Stroke<\/i> 1991; 22: 983\u2013988.","DOI":"10.1161\/01.STR.22.8.983"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yamashita Y, Hamatani Y, Esato M, Chun YH, Tsuji H, Wada H, et al. Clinical characteristics and outcomes in extreme elderly (age \u226585 years) Japanese patients with atrial fibrillation: The Fushimi AF Registry. <i>Chest<\/i> 2016; 149: 401\u2013412.","DOI":"10.1378\/chest.15-1095"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Torn M, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR. Risks of oral anticoagulant therapy with increasing age. <i>Arch Intern Med<\/i> 2005; 165: 1527\u20131532.","DOI":"10.1001\/archinte.165.13.1527"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. <i>Ann Intern Med<\/i> 1999; 131: 492\u2013501.","DOI":"10.7326\/0003-4819-131-7-199910050-00003"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials. <i>Lancet<\/i> 2014; 383: 955\u2013962, doi:10.1016\/S0140-6736(13)62343-0.","DOI":"10.1016\/S0140-6736(13)62343-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Okumura K, Akao M, Yoshida T, Kawata M, Okazaki O, Akashi S, et al. Low-dose edoxaban in very elderly patients with atrial fibrillation. <i>N Engl J Med<\/i> 2020; 383: 1735\u20131745.","DOI":"10.1056\/NEJMoa2012883"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Barssoum K, Kumar A, Thakkar S, Sheth AR, Kharsa A, Ibrahim M, et al. Meta-analysis of safety and efficacy of anticoagulation versus no anticoagulation in octogenarians and nonagenarians with atrial fibrillation. <i>High Blood Press Cardiovasc Prev<\/i> 2021; 28: 271\u2013282.","DOI":"10.1007\/s40292-021-00442-0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yamashita T, Suzuki S, Inoue H, Akao M, Atarashi H, Ikeda T, et al. Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: Results from the All Nippon AF In the Elderly (ANAFIE) Registry. <i>Eur Heart J Qual Care Clin Outcomes<\/i> 2022; 8: 202\u2013213.","DOI":"10.1093\/ehjqcco\/qcab025"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hiasa KI, Kaku H, Inoue H, Yamashita T, Akao M, Atarashi H, et al. Age-related differences in the clinical characteristics and treatment of elderly patients with atrial fibrillation in Japan: Insight from the ANAFIE (All Nippon AF In Elderly) Registry. <i>Circ J<\/i> 2020; 84: 388\u2013396.","DOI":"10.1253\/circj.CJ-19-0898"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Inoue H, Yamashita T, Akao M, Atarashi H, Ikeda T, Okumura K, et al. Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry. <i>J Cardiol<\/i> 2018; 72: 300\u2013306.","DOI":"10.1016\/j.jjcc.2018.02.018"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Koretsune Y, Yamashita T, Akao M, Atarashi H, Ikeda T, Okumura K, et al. Baseline demographics and clinical characteristics in the All Nippon AF in the Elderly (ANAFIE) Registry. <i>Circ J<\/i> 2019; 83: 1538\u20131545.","DOI":"10.1253\/circj.CJ-19-0094"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Akao M, Shimizu W, Atarashi H, Ikeda T, Inoue H, Okumura K, et al. Oral anticoagulant use in elderly Japanese patients with non-valvular atrial fibrillation: Subanalysis of the ANAFIE Registry. <i>Circ Rep<\/i> 2020; 2: 552\u2013559.","DOI":"10.1253\/circrep.CR-20-0082"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Akao M, Inoue H, Yamashita T, Atarashi H, Ikeda T, Koretsune Y, et al. Relationship between direct oral anticoagulant doses and clinical outcomes in elderly patients with non-valvular atrial fibrillation: ANAFIE Registry sub-analysis. <i>Circ J<\/i> 2023; 87: 1765\u20131774.","DOI":"10.1253\/circj.CJ-23-0143"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Suzuki S, Yamashita T, Akao M, Atarashi H, Ikeda T, Okumura K, et al. Clinical phenotypes of older adults with non-valvular atrial fibrillation not treated with oral anticoagulants by hierarchical cluster analysis in the ANAFIE Registry. <i>PLoS One<\/i> 2023; 18: e0280753.","DOI":"10.1371\/journal.pone.0280753"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chao TF, Liu CJ, Lin YJ, Chang SL, Lo LW, Hu YF, et al. Oral anticoagulation in very elderly patients with atrial fibrillation: A nationwide cohort study. <i>Circulation<\/i> 2018; 138: 37\u201347.","DOI":"10.1161\/CIRCULATIONAHA.117.031658"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Raposeiras-Roub\u00edn S, Alonso Rodr\u00edguez D, Camacho Freire SJ, Abu-Assi E, Cobas-Paz R, Pascual CR, et al. Vitamin K antagonists and direct oral anticoagulants in nonagenarian patients with atrial fibrillation. <i>J Am Med Dir Assoc<\/i> 2020; 21: 367\u2013373.e1.","DOI":"10.1016\/j.jamda.2019.08.033"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Siu CW, Tse HF. Net clinical benefit of warfarin therapy in elderly Chinese patients with atrial fibrillation. <i>Circ Arrhythm Electrophysiol<\/i> 2014; 7: 300\u2013306.","DOI":"10.1161\/CIRCEP.113.000858"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Appelros P, Farahmand B, Ter\u00e9nt A, \u00c5sberg S. To treat or not to treat: Anticoagulants as secondary preventives to the oldest old with atrial fibrillation. <i>Stroke<\/i> 2017; 48: 1617\u20131623.","DOI":"10.1161\/STROKEAHA.117.016902"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Carnicelli AP, Hong H, Connolly SJ, Eikelboom J, Giugliano RP, Morrow DA, et al; COMBINE AF (A Collaboration Between Multiple Institutions to Better Investigate Non-Vitamin K Antagonist Oral Anticoagulant Use in Atrial Fibrillation) Investigators. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: Patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. <i>Circulation<\/i> 2022; 145: 242\u2013255.","DOI":"10.1161\/CIRCULATIONAHA.121.056355"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Silverio A, Di Maio M, Prota C, De Angelis E, Radano I, Citro R, et al. Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: Systematic review and meta-analysis of 22 studies and 440 281 patients. <i>Eur Heart J Cardiovasc Pharmacother<\/i> 2021; 7: f20\u2013f29.","DOI":"10.1093\/ehjcvp\/pvz073"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Chan YH, Chan CY, Chen SW, Chao TF, Lip GYH. Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: A systematic review and meta-analysis of observational studies. <i>Europace<\/i> 2023; 25: euad288.","DOI":"10.1093\/europace\/euad288"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Joosten LPT, van Doorn S, van de Ven PM, K\u00f6hlen BTG, Nierman MC, Koek HL, et al. Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: Results of the FRAIL-AF randomized controlled trial. <i>Circulation<\/i> 2024; 149: 279\u2013289.","DOI":"10.1161\/CIRCULATIONAHA.123.066485"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Chiang CE, Chao TF, Choi EK, Lim TW, Krittayaphong R, Li M, et al. Stroke prevention in atrial fibrillation: A scientific statement of JACC: Asia (Part 2). <i>JACC Asia<\/i> 2022; 2: 519\u2013537.","DOI":"10.1016\/j.jacasi.2022.06.004"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Okumura K, Yamashita T, Suzuki S, Akao M; J-ELD AF Investigators. A multicenter prospective cohort study to investigate the effectiveness and safety of apixaban in Japanese elderly atrial fibrillation patients (J-ELD AF Registry). <i>Clin Cardiol<\/i> 2020; 43: 251\u2013259.","DOI":"10.1002\/clc.23294"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ogawa H, An Y, Ishigami K, Ikeda S, Doi K, Hamatani Y, et al. Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: The Fushimi AF registry. <i>Eur Heart J Qual Care Clin Outcomes<\/i> 2021; 7: 163\u2013171.","DOI":"10.1093\/ehjqcco\/qcaa082"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Yu JH, Li PR, Chen DY, Huang WK, See LC. Mortality after major bleeding in Asian atrial fibrillation patients receiving different direct oral anticoagulants: A nationwide, propensity score study. <i>Sci Rep<\/i> 2024; 14: 4771.","DOI":"10.1038\/s41598-024-55500-z"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, et al. 2021 Focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive summary. <i>Thromb Haemost<\/i> 2022; 122: 20\u201347.","DOI":"10.1055\/s-0041-1739411"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Akishita M, Suzuki S, Inoue H, Akao M, Atarashi H, Ikeda T, et al. Frailty and outcomes in older adults with non-valvular atrial fibrillation from the ANAFIE registry. <i>Arch Gerontol Geriatr<\/i> 2022; 101: 104661.","DOI":"10.1016\/j.archger.2022.104661"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kreutz R, Schmidt IM, Dr\u00e4ger D, Br\u00fcggen F, H\u00f6rter S, Zwillich C, et al. Atrial fibrillation and medication treatment among centenarians: Are all very old patients treated the same? <i>Geriatr Gerontol Int<\/i> 2018; 18: 1634\u20131640.","DOI":"10.1111\/ggi.13531"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/6\/8\/6_CR-24-0061\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T03:25:57Z","timestamp":1723260357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/6\/8\/6_CR-24-0061\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-24-0061","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]},"article-number":"CR-24-0061"}}